Tri-complex inhibitors (TCIs) are molecular glues that bind to active GTP-bound RAS and recruit the intracellular chaperone cyclophilin A (CYPA) to generate a synthetic inhibitory complex that blocks ...

An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...

President Trump signed a long-awaited executive order on Tuesday that aims to mitigate security threats posed by artificial intelligence, in a shift from the administration's hands-off approach to the ...

If you are interested in building your skills as a peer reviewer, please consult our free online course Focus on Peer Review from Nature Masterclasses for detailed insight into the peer review process ...